AC

Arlindo L. Castelhano

OP Osi Pharmaceuticals: 25 patents #1 of 181Top 1%
S( Syntex (U.S.A.): 15 patents #20 of 599Top 4%
AP Agouron Pharmaceuticals: 10 patents #19 of 327Top 6%
TI The Wistar Institute: 2 patents #26 of 103Top 30%
PL Prosidion Limited: 1 patents #18 of 38Top 50%
CP Cadus Pharmaceutical: 1 patents #11 of 15Top 75%
SY Syntex: 1 patents #3 of 48Top 7%
📍 Mississauga, CA: #38 of 3,799 inventorsTop 2%
Overall (All Time): #56,164 of 4,157,543Top 2%
49
Patents All Time

Issued Patents All Time

Showing 1–25 of 49 patents

Patent #TitleCo-InventorsDate
12116359 EBNA1 inhibitor crystalline forms, and methods of preparing and using same Troy E. Messick, Paul Lieberman, Garry Robert Smith 2024-10-15
11242338 EBNA1 inhibitor crystalline forms, and methods of preparing and using same Troy E. Messick, Paul Lieberman, Garry Robert Smith 2022-02-08
8557814 mTOR inhibitor salt forms Kristen Michelle Mulvihill, Gary Conard Visor 2013-10-15
7829717 (Arylamidoaryl)squaramide compounds Andrew P. Crew, Hanqing Dong, An-Hu Li, Li Qiu, Alun John Smith +2 more 2010-11-09
7767673 N-substituted imidazopyridine c-Kit inhibitors Andrew P. Crew, Han-Qing Dong, Radoslaw Laufer, An-Hu Li, Li Qiu +2 more 2010-08-03
7662844 Naphthylene derivatives as cytochrome P450 inhibitors Vanessa Smith, Anthony Nigro, Mark J. Mulvihill, Cara Cesario, Patricia Anne Beck 2010-02-16
7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use Bryan McKibben, Arno G. Steinig 2010-01-12
7598252 Compounds specific to adenosine A, receptors and uses thereof Bryan McKibben, David J. Witter 2009-10-06
7521448 N-substituted benzimidazolyl c-Kit inhibitors Joshua Bolger, Andrew P. Crew, Han-Qing Dong, Ayako Honda, Radoslaw Laufer +7 more 2009-04-21
7504407 Compounds specific to adenosine A1 and A3 receptors and uses thereof Bryan McKibben, Douglas S. Werner, David J. Witter 2009-03-17
7501407 Pyrimidine A2B selective antagonist compounds, their synthesis and use Bryan McKibben, Arno G. Steinig, Eric W. Collington 2009-03-10
7485658 N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors Joshua Bolger, Andrew P. Crew, Radoslaw Laufer, An-Hu Li, Colin Peter Sambrook Smith +1 more 2009-02-03
7442709 N3-substituted imidazopyridine c-Kit inhibitors Andrew P. Crew, Han-Qing Dong, Radoslaw Laufer, An-Hu Li, Li Qiu +2 more 2008-10-28
7439256 (Arylamidoaryl) cyanoguanidine compounds Andrew P. Crew, Hanqing Dong, An-Hu Li, Li Qiu, Alun John Smith 2008-10-21
7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use Bryan McKibben, David J. Witter 2008-09-30
7262196 Tri(cyclo) substituted amide glucokinase activator compounds Matthew Colin Thor Fyfe, Lisa Sarah Gardner, Maseo Nawano, Martin James Procter, Chrystelle Marie Rasamison +3 more 2007-08-28
7160890 Compounds specific to adenosine A3 receptor and uses thereof Bryan McKibben, David J. Witter 2007-01-09
7064122 Pancreatic lipase inhibitor compounds, their synthesis and use David J. Witter 2006-06-20
6949563 (2-carboxamido)(3-amino)thiophene compounds Graham Michael Wynne, Kevin James Doyle, Saleh Ahmed, An-Hu Li, John Keily +9 more 2005-09-27
6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use Bryan McKibben, Arno G. Steinig, Eric W. Collington 2005-07-12
6878716 Compounds specific to adenosine A1 receptor and uses thereof Bryan McKibben, David J. Witter 2005-04-12
6800633 Pyrrolo[2,3d]pyrimidine compositions and their use Bryan McKibben, David J. Witter 2004-10-05
6686366 Compounds specific to adenosine A3 receptor and uses thereof Bryan McKibben, David J. Witter 2004-02-03
6680322 Compounds specific to adenosine A1 receptors and uses thereof Bryan McKibben, David J. Witter 2004-01-20
6680324 Compounds specific to adenosine A1 receptors and uses thereof Bryan McKibben, David J. Witter 2004-01-20